InsidersTradesSigma
Genscript Biotech Corporation Stock: price and insider trades · Hong Kong · HKEX
Track the Genscript Biotech Corporation share price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares are quoted on HK HK, under the authority of HKEX. Operating in the Health Care sector, Genscript Biotech Corporation has recorded 12 public disclosures. Market capitalisation: €30.2bn. The latest transaction was disclosed on 26 June 2026 (Other). Among the most active insiders: Zhang Fangliang. All data is accessible without an account.
12
Insider Decl.
0
Thresholds
·
5 ops.
Buy Volume
€446,542
3 ops.
Sell Volume
25Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 20,287 of 26,451 companies
33.2
score / 100
Value35
Quality32
FCF yld0.8%
Earn yld-1.7%
EV/EBITDA·
ROE-13%
Gross mgn58%
Net mgn-56%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 26 June 2026
Declarations12 total
3,907,209 sharesShareXHKGHKEX:DA20260625E00322
7,693,304 sharesShareXHKGHKEX:DA20260625E00320
5,270,879 sharesShareXHKGHKEX:DA20260625E00318
169,561 sharesShareXHKGHKEX:DA20260609E00356
Ideal exit: 1 Mar 2027 (T+270)
313,650 shares@ €1.34140.0016% mcap95.1% of flowShareXHKGHKEX:DA20260609E00352
113,041 sharesShareXHKGHKEX:DA20260609E00361
Ideal exit: 1 Mar 2027 (T+270)
841,470 sharesShareXHKGHKEX:DA20260609E00353
Ideal exit: 1 Mar 2027 (T+270)
16,071 shares@ €1.35430.0001% mcap100.0% of flowShareXHKGHKEX:DA20260410E00415
12 of 12 declarations
About Genscript Biotech Corporation
Genscript Biotech Corporation is a biotechnology company that provides research services and products for drug development. It is listed on the Hong Kong Stock Exchange.